near-significantP =.05
However, clinicians showed a near-significant advantage over ChatGPT-4o (20/35, 57% vs 11/35, 31%; OR 0.34, 95% CI 0.13‐0.91; P =.05; Tables3 4 ).
However, clinicians showed a near-significant advantage over ChatGPT-4o (20/35, 57% vs 11/35, 31%; OR 0.34, 95% CI 0.13‐0.91; P =.05; Tables3 4 ).